KPIs & Operating Metrics(New)
Biologics And Drug Delivery Revenue By CategoryBiologics And Drug Delivery Revenue By Category AnnualBreakdown Of AssetsCapital Equipment And Software Revenue By CategoryCapital Equipment And Software Revenue By Category AnnualCost Of RevenueDeferred RevenueEmployee StatisticsFunctional Neurosurgery Navigation And Therapy Revenue By CategoryFunctional Neurosurgery Navigation And Therapy Revenue By Category AnnualGross Margin %Gross ProfitOpex As A % Of Total Revenue %OPEX SegregationProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment, Net BreakdownRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Service LineRevenue By Service Line %Revenue By Service Line AnnualRevenue By Service Line Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Cost Of Revenue (2018 - 2025)

ClearPoint Neuro's Cost of Revenue history spans 13 years, with the latest figure at $3.8 million for Q3 2025.

  • For Q3 2025, Cost of Revenue rose 8.14% year-over-year to $3.8 million; the TTM value through Sep 2025 reached $12.6 million, down 5.06%, while the annual FY2024 figure was $12.3 million, 18.63% up from the prior year.
  • Cost of Revenue for Q3 2025 was $3.8 million at ClearPoint Neuro, up from $3.7 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $4.1 million in Q4 2022 and bottomed at $95000.0 in Q4 2021.
  • The 5-year median for Cost of Revenue is $2.8 million (2023), against an average of $2.5 million.
  • The largest annual shift saw Cost of Revenue soared 4264.21% in 2022 before it tumbled 36.68% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $95000.0 in 2021, then skyrocketed by 4264.21% to $4.1 million in 2022, then plummeted by 32.54% to $2.8 million in 2023, then plummeted by 36.68% to $1.8 million in 2024, then skyrocketed by 116.71% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Cost of Revenue are $3.8 million (Q3 2025), $3.7 million (Q2 2025), and $3.4 million (Q1 2025).